<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.tem.2026.01.011</dc:identifier><dc:language>eng</dc:language><dc:creator>Mainé-Rodrigo, Aldara</dc:creator><dc:creator>Vela-Sebastián, Ana</dc:creator><dc:creator>Pacheu-Grau, David</dc:creator><dc:title>Reversible phosphorylation influences energetic cellular metabolism by modulating mitochondrial gene expression</dc:title><dc:identifier>ART-2026-148761</dc:identifier><dc:description>Mitochondria act as key metabolic regulators beyond ATP production, and the understanding of how cellular signaling modifies mitochondrial gene expression is currently being explored. Recent evidence links kinases such as mitogen-activated protein kinase-interacting kinases, hexokinase 1, and eukaryotic elongation factor 2 kinase to mitochondrial function, influencing metabolic adaptation, inflammation, and survival under nutrient stress, with implications for obesity and aging.</dc:description><dc:date>2026</dc:date><dc:source>http://zaguan.unizar.es/record/170185</dc:source><dc:doi>10.1016/j.tem.2026.01.011</dc:doi><dc:identifier>http://zaguan.unizar.es/record/170185</dc:identifier><dc:identifier>oai:zaguan.unizar.es:170185</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/AEI/PID2023-147275NB-I00</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B33-23R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MICINN/CNS2023-144637</dc:relation><dc:identifier.citation>TRENDS IN ENDOCRINOLOGY AND METABOLISM 37, 3 (2026), 186-189</dc:identifier.citation><dc:rights>All rights reserved</dc:rights><dc:rights>http://www.europeana.eu/rights/rr-f/</dc:rights><dc:rights>info:eu-repo/semantics/closedAccess</dc:rights></dc:dc>

</collection>